SCHEMBL1048091

SCHEMBL1048091

COc1cccc(CNC(=O)c2c(-c3ccccc3)c(C)cn2Cc2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
KDM4E B2RXH2 1/20 0.53
USP2 O75604 1/20 0.53
MMP13 P45452 3/20 0.52
MAPT P10636 2/20 0.52
RAB9A P51151 1/20 0.51
KLKB1 P03952 2/20 0.50
LMNA P02545 2/20 0.49
TP53 P04637 1/20 0.49
POLB P06746 1/20 0.49
APEX1 P27695 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PTGER4 P35408 1/20 0.48
AURKA O14965 1/20 0.48
ROCK2 O75116 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1030311 0.84 ALDH1A1 (0.47) ALDH1A1HPGDMMP13MAPTRAB9A
SCHEMBL1031909 0.81 NPC1 (0.47) ALDH1A1HPGDRAB9ALMNATP53
SCHEMBL1031517 0.79 KDM4E (0.46) ALDH1A1KDM4EMMP13MAPTKLKB1
SCHEMBL1027523 0.79 PTGER4 (0.49) MMP13KLKB1PTGER4
SCHEMBL1031509 0.78 WDR5 (0.51) ALDH1A1MMP13KLKB1TP53ROCK2
SCHEMBL1031863 0.78 SMN1; SMN2 (0.50) ALDH1A1MAPTLMNATP53SMN1; SMN2
SCHEMBL8784569 0.77 TACR1 (0.58) ALDH1A1HPGDKDM4EUSP2MMP13
SCHEMBL1028724 0.77 POLB (0.51) ALDH1A1HPGDKDM4EMAPTRAB9A
SCHEMBL1029323 0.77 MAPK14 (0.57) MMP13ROCK2ROCK1
SCHEMBL2638817 0.75 NOTUM (0.48) ALDH1A1HPGDKDM4ELMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968591-B2 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use in medicaments GRUENENTHAL GMBH (DE) 2011-06-28 US claimed
EP-2035375-B1 1,3-DISUBSTITUTED 4-METHYL-1H-PYRROLE-2-CARBOXAMIDES AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-01-19 EP claimed
US-20090137573-A1 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments GRUENENTHAL GMBH (DE) 2009-05-28 US claimed
US-7968591-B2 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use in medicaments GRUENENTHAL GMBH (DE) 2011-06-28 US disclosed
US-20090137573-A1 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments GRUENENTHAL GMBH (DE) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137573-A1 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments OPRL1, TPH1, OPRK1 ALDH1A1 2168/4885HPGD 936/4885KDM4E 829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.